Lu Timothy's most recent trade in Senti Biosciences Inc. was a trade of 1,927,073 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Senti Biosciences Inc. | Timothy Lu | Director, CEO and Interim PFO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,927,073 | 1,927,073 | - | - | Stock Option (Right to Buy) | |
Senti Biosciences Inc. | Timothy Lu | Director, CEO and Interim PFO and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 642,358 | 724,440 | - | 0 | Common Stock | |
Senti Biosciences Inc. | Timothy Lu | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.07 per share. | 04 Feb 2025 | 3,922 | 82,627 | - | 4.1 | 15,963 | Common Stock |
Senti Biosciences Inc. | Timothy Lu | Director, CEO | Sale of securities on an exchange or to another person at price $ 4.36 per share. | 04 Feb 2025 | 545 | 82,082 | - | 4.4 | 2,376 | Common Stock |
Senti Biosciences Inc. | Timothy Lu | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 459,000 | 459,000 | - | - | Stock Option (Right to Buy) | |
Senti Biosciences Inc. | Lu Timothy | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 306,000 | 865,496 | - | 0 | Common Stock | |
Senti Biosciences Inc. | Timothy Lu | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 630,000 | 630,000 | - | - | Stock Option (Right to Buy) |